Literature DB >> 31809571

Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion.

Stuart P Moon, Aaron T Balana, Ana Galesic, Ananya Rakshit, Matthew R Pratt.   

Abstract

Toxic amyloid aggregates are a feature of many neurodegenerative diseases. A number of biochemical and structural studies have demonstrated that not all amyloids of a given protein are equivalent but rather that an aggregating protein can form different amyloid structures or polymorphisms. Different polymorphisms can also induce different amounts of pathology and toxicity in cells and in mice, suggesting that the structural differences may play important roles in disease. However, the features that cause the formation of polymorphisms in vivo are still being uncovered. Posttranslational modifications on several amyloid forming proteins, including the Parkinson's disease causing protein α-synuclein, may be one such cause. Here, we explore whether ubiquitination can induce structural changes in α-synuclein aggregates in vitro. We used protein chemistry to first synthesize ubiquitinated analogues at three different positions using disulfide linkages. After aggregation, these linkages can be reversed, allowing us to make relative comparisons between the structures using a proteinase K assay. We find that, while ubiquitination at residue 6, 23, or 96 inhibits α-synuclein aggregation, only modification at residue 96 causes an alteration in the aggregate structure, providing further evidence that posttranslational modifications may be an important feature in amyloid polymorphism formation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31809571      PMCID: PMC7097865          DOI: 10.1021/acs.joc.9b02641

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  50 in total

1.  Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation.

Authors:  Franziska Meier; Tharindumala Abeywardana; Abhinav Dhall; Nicholas P Marotta; Jobin Varkey; Ralf Langen; Champak Chatterjee; Matthew R Pratt
Journal:  J Am Chem Soc       Date:  2012-03-14       Impact factor: 15.419

2.  Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated α-synuclein.

Authors:  Mirva Hejjaoui; Mahmood Haj-Yahya; K S Ajish Kumar; Ashraf Brik; Hilal A Lashuel
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-10       Impact factor: 15.336

3.  Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.

Authors:  Katerina E Paleologou; Abid Oueslati; Gideon Shakked; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Claudio O Fernandez; Adrian Schmid; Fariba Chegini; Wei Ping Gai; Diego Chiappe; Marc Moniatte; Bernard L Schneider; Patrick Aebischer; David Eliezer; Markus Zweckstetter; Eliezer Masliah; Hilal A Lashuel
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

4.  Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Tapan P Patel; Selcuk A Tanik; Dawn M Riddle; Anna Stieber; David F Meaney; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

5.  Ultrafast protein splicing is common among cyanobacterial split inteins: implications for protein engineering.

Authors:  Neel H Shah; Geoffrey P Dann; Miquel Vila-Perelló; Zhihua Liu; Tom W Muir
Journal:  J Am Chem Soc       Date:  2012-07-02       Impact factor: 15.419

6.  Perturbation in Long-Range Contacts Modulates the Kinetics of Amyloid Formation in α-Synuclein Familial Mutants.

Authors:  Priyatosh Ranjan; Ashutosh Kumar
Journal:  ACS Chem Neurosci       Date:  2017-08-14       Impact factor: 4.418

7.  Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins.

Authors:  Jobin Varkey; Jose Mario Isas; Naoko Mizuno; Martin Borch Jensen; Vikram Kjøller Bhatia; Christine C Jao; Jitka Petrlova; John C Voss; Dimitrios G Stamou; Alasdair C Steven; Ralf Langen
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

8.  Native Chemical Ligation and Extended Methods: Mechanisms, Catalysis, Scope, and Limitations.

Authors:  Vangelis Agouridas; Ouafâa El Mahdi; Vincent Diemer; Marine Cargoët; Jean-Christophe M Monbaliu; Oleg Melnyk
Journal:  Chem Rev       Date:  2019-05-03       Impact factor: 60.622

9.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 10.  Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role.

Authors:  Marco Emanuele; Evelina Chieregatti
Journal:  Biomolecules       Date:  2015-05-13
View more
  7 in total

1.  Effects of Glutamate Arginylation on α-Synuclein: Studying an Unusual Post-Translational Modification through Semisynthesis.

Authors:  Buyan Pan; Naoki Kamo; Marie Shimogawa; Yun Huang; Anna Kashina; Elizabeth Rhoades; E James Petersson
Journal:  J Am Chem Soc       Date:  2020-12-18       Impact factor: 15.419

Review 2.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

Review 3.  Atypical Ubiquitination and Parkinson's Disease.

Authors:  Olga Buneeva; Alexei Medvedev
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 4.  Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease.

Authors:  Hajung Yoo; Jeongmin Lee; Bokwang Kim; Heechang Moon; Huisu Jeong; Kyungmi Lee; Woo Jeung Song; Junho K Hur; Yohan Oh
Journal:  BMB Rep       Date:  2022-07       Impact factor: 5.041

Review 5.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26

Review 6.  Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications.

Authors:  Rosie Bell; Michele Vendruscolo
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

Review 7.  Consequences of post-translational modifications on amyloid proteins as revealed by protein semisynthesis.

Authors:  Stuart P Moon; Aaron T Balana; Matthew R Pratt
Journal:  Curr Opin Chem Biol       Date:  2021-06-25       Impact factor: 8.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.